Thomas F Whayne1,2, Sibu P Saha3. 1. Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY, USA. twhayn0@uky.edu. 2. Gill Heart and Vascular Institute, 326 Wethington Building, 900 South Limestone Street, Lexington, KY, 40356-0200, USA. twhayn0@uky.edu. 3. Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to investigate and discuss two aspects of coronary artery disease (CAD)-genetic risk and therapeutic lifestyle change (TLC)-both of which have key importance for patients and their care but which actually receive inadequate attention. RECENT FINDINGS: Genetic risk has generally been relegated to a broad association with the presence of one or more inherited cardiovascular (CV) risk factors such as hypercholesterolemia, family history of atherosclerosis, hypertension, and diabetes mellitus. However, the future of genetic risk is an understanding of specific genes, a genetic risk score, specific genetic loci known as selective nucleotide polymorphisms (SNPs), specific alleles, and microribonucleic acids (miRNAs). Healthy lifestyle is fashionably referred to as TLC and encompasses physical fitness, exercise, behavioral modification, diet, and stress reduction. In the past decade, aggressive treatment of cholesterol with statins has received the major emphasis for CV risk reduction. Genetics, of course, can only be modified by factors that influence epigenetics, and TLC could have an effect on genetics by this mechanism. On the other hand, each individual component of TLC has been shown to contribute to a reduction of CV risk. Although aggressive pharmaceutical approaches are now in vogue, whatever TLC can contribute, depending on the degree of individual patient adherence, should never be forgotten.
PURPOSE OF REVIEW: The purpose of this review is to investigate and discuss two aspects of coronary artery disease (CAD)-genetic risk and therapeutic lifestyle change (TLC)-both of which have key importance for patients and their care but which actually receive inadequate attention. RECENT FINDINGS: Genetic risk has generally been relegated to a broad association with the presence of one or more inherited cardiovascular (CV) risk factors such as hypercholesterolemia, family history of atherosclerosis, hypertension, and diabetes mellitus. However, the future of genetic risk is an understanding of specific genes, a genetic risk score, specific genetic loci known as selective nucleotide polymorphisms (SNPs), specific alleles, and microribonucleic acids (miRNAs). Healthy lifestyle is fashionably referred to as TLC and encompasses physical fitness, exercise, behavioral modification, diet, and stress reduction. In the past decade, aggressive treatment of cholesterol with statins has received the major emphasis for CV risk reduction. Genetics, of course, can only be modified by factors that influence epigenetics, and TLC could have an effect on genetics by this mechanism. On the other hand, each individual component of TLC has been shown to contribute to a reduction of CV risk. Although aggressive pharmaceutical approaches are now in vogue, whatever TLC can contribute, depending on the degree of individual patient adherence, should never be forgotten.
Authors: Ramón Estruch; Emilio Ros; Jordi Salas-Salvadó; Maria-Isabel Covas; Dolores Corella; Fernando Arós; Enrique Gómez-Gracia; Valentina Ruiz-Gutiérrez; Miquel Fiol; José Lapetra; Rosa Maria Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Josep Basora; Miguel Angel Muñoz; José V Sorlí; José Alfredo Martínez; Miguel Angel Martínez-González Journal: N Engl J Med Date: 2013-02-25 Impact factor: 91.245
Authors: Catherine S Bennet; Chanukya R Dahagam; Salim S Virani; Seth S Martin; Roger S Blumenthal; Erin D Michos; John W McEvoy Journal: Am J Med Date: 2016-05-03 Impact factor: 4.965
Authors: Emanuele Di Angelantonio; Pei Gao; Lisa Pennells; Stephen Kaptoge; Muriel Caslake; Alexander Thompson; Adam S Butterworth; Nadeem Sarwar; David Wormser; Danish Saleheen; Christie M Ballantyne; Bruce M Psaty; Johan Sundström; Paul M Ridker; Dorothea Nagel; Richard F Gillum; Ian Ford; Pierre Ducimetiere; Stefan Kiechl; Wolfgang Koenig; Robin P F Dullaart; Gerd Assmann; Ralph B D'Agostino; Gilles R Dagenais; Jackie A Cooper; Daan Kromhout; Altan Onat; Robert W Tipping; Agustín Gómez-de-la-Cámara; Annika Rosengren; Susan E Sutherland; John Gallacher; F Gerry R Fowkes; Edoardo Casiglia; Albert Hofman; Veikko Salomaa; Elizabeth Barrett-Connor; Robert Clarke; Eric Brunner; J Wouter Jukema; Leon A Simons; Manjinder Sandhu; Nicholas J Wareham; Kay-Tee Khaw; Jussi Kauhanen; Jukka T Salonen; William J Howard; Børge G Nordestgaard; Angela M Wood; Simon G Thompson; S Matthijs Boekholdt; Naveed Sattar; Chris Packard; Vilmundur Gudnason; John Danesh Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: Kirsten K Ness; Zhaoming Wang; Nan Song; Zhenghong Li; Na Qin; Carrie R Howell; Carmen L Wilson; John Easton; Heather L Mulder; Michael N Edmonson; Michael C Rusch; Jinghui Zhang; Melissa M Hudson; Yutaka Yasui; Leslie L Robison Journal: Clin Cancer Res Date: 2020-01-22 Impact factor: 12.531
Authors: Karam Basham; Ahmed Aldubaikhi; Ihab Sulaiman; Abdullah Alhaider; Ahmed Alrasheed; Fahad Bahanan; Emad Masuadi; Abdulmalik Alsaif Journal: J Family Med Prim Care Date: 2021-11-05
Authors: Emy A Thomas; Nitesh Enduru; Adrienne Tin; Eric Boerwinkle; Michael E Griswold; Thomas H Mosley; Rebecca F Gottesman; Myriam Fornage Journal: J Am Heart Assoc Date: 2022-07-20 Impact factor: 6.106